
Opinion|Videos|November 11, 2024
Diagnostic Challenges and Treatment Impact in Vitiligo Management
Author(s)Seemal Desai, MD, FAAD
Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying disease subtypes and distinguishing vitiligo from other depigmentation disorders.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- What immune and genetic factors drive the development and progression of vitiligo?
- What are the biggest challenges in diagnosing vitiligo and its subtypes?
- How do these subtypes impact treatment initiation and outcomes?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
Cancer survival fell and deaths rose during first two years of COVID-19
4
TrumpRx launches; some experts question its long-term value
5























